CoChat

Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy

Crawford, Abbe H., Hildyard, John C. W., Rushing, Sophie A. M., Wells, Dominic J., Diez-Leon, Maria, Piercy, Richard J. · 2022 · Disease Models & Mechanisms
Cited by 17

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Duchenne muscular dystrophy (DMD), a fatal musculoskeletal disease, is associated with neurodevelopmental disorders and cognitive impairment caused by brain dystrophin deficiency. Dog models of DMD represent key translational tools to study dystrophin biology and to develop novel therapeutics. However, characterisation of dystrophin expression and function in the canine brain is lacking. We studied the DE50-MD canine model of DMD that has a missense mutation in the donor splice site of exon 50. Using a battery of cognitive tests, we detected a neurocognitive phenotype in DE50-MD dogs, including reduced attention, problem solving and exploration of novel objects. Through a combination of capillary immunoelectrophoresis, immunolabelling, quantitative PCR and RNAScope in situ hybridisation, we show that regional dystrophin expression in the adult canine brain reflects that of humans, and that the DE50-MD dog lacks full-length dystrophin (Dp427) protein expression but retains expression of the two shorter brain-expressed isoforms, Dp140 and Dp71. Thus, the DE50-MD dog is a translationally relevant pre-clinical model to study the consequences of Dp427 deficiency in the brain and to develop therapeutic strategies for the neurological sequelae of DMD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/dmm.049291

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 83

  1. Agostino, 2008, Voluntary, spontaneous, and reflex blinking in Parkinson's disease, Mov. Disord., 23, 669, 10.1002/mds.21887 · DOI
  2. Austin, 1995, Cloning and characterization of alternatively spliced isoforms of Dp71, Hum. Mol. Genet., 4, 1475, 10.1093/hmg/4.9.1475 · doi:10.1093/hmg/4.9.1475
  3. Banihani, 2015, Cognitive and neurobehavioral profile in boys with Duchenne muscular dystrophy, J. Child Neurol., 30, 1472, 10.1177/0883073815570154 · DOI · Paper page
  4. Bar, 1990, A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution, Biochem. J., 272, 557, 10.1042/bj2720557 · DOI · Paper page
  5. Bardoni, 2000, Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies, Neuromuscul. Disord., 10, 194, 10.1016/S0960-8966(99)00108-X · DOI
  6. Bologna, 2009, Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy, Brain, 132, 502, 10.1093/brain/awn317 · DOI
  7. Byers, 1993, An alternative dystrophin transcript specific to peripheral nerve, Nat. Genet., 4, 77, 10.1038/ng0593-77 · DOI · Paper page
  8. Caplan, 1998, Blink rate in pediatric complex partial seizure disorder, J. Child Psychol. Psychiatry, 39, 1145, 10.1111/1469-7610.00418 · DOI
  9. Carter, 1996, A splicing-dependent regulatory mechanism that detects translation signals, EMBO J., 15, 5965, 10.1002/j.1460-2075.1996.tb00983.x · DOI · Paper page
  10. Chamova, 2013, Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies, Balkan. J. Med. Genet., 16, 21, 10.2478/bjmg-2013-0014 · DOI · Paper page
  11. Cotton, 2001, Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients, Dev. Med. Child Neurol., 43, 497, 10.1017/S0012162201000913 · DOI · Paper page
  12. Crawford, 2021, Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs, Wellcome Open Res., 6, 84, 10.12688/wellcomeopenres.16707.1 · doi:10.12688/wellcomeopenres.16707.1
  13. Daffner, 1994, The impact of aging on curiosity as measured by exploratory eye movements, Arch. Neurol., 51, 368, 10.1001/archneur.1994.00540160062009 · DOI
  14. Daffner, 1999, Mechanisms underlying diminished novelty-seeking behavior in patients with probable Alzheimer's disease, Neuropsychiatr. Neuropsychol. Behav. Neurol., 12, 58
  15. Daffner, 2000, The central role of the prefrontal cortex in directing attention to novel events, Brain, 123, 927, 10.1093/brain/123.5.927 · DOI · Paper page
  16. Daffner, 2006, Increased responsiveness to novelty is associated with successful cognitive aging, J. Cogn. Neurosci., 18, 1759, 10.1162/jocn.2006.18.10.1759 · DOI
  17. Daoud, 2008, Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions, PLoS ONE, 4, e6574, 10.1371/journal.pone.0006574 · DOI · Paper page
  18. Doorenweerd, 2014, Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy, Ann. Neurol., 76, 403, 10.1002/ana.24222 · DOI · Paper page
  19. Doorenweerd, 2017, Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy, Sci. Rep., 7, 12575, 10.1038/s41598-017-12981-5 · DOI · Paper page
  20. D'souza, 1995, A novel dystrophin isoform is required for normal retinal electrophysiology, Hum. Mol. Genet., 4, 837, 10.1093/hmg/4.5.837 · DOI · Paper page
  21. Fabiani, 1998, Individual differences in P3 scalp distribution in older adults, and their relationship to frontal lobe function, Psychophysiology, 35, 698, 10.1111/1469-8986.3560698 · doi:10.1111/1469-8986.3560698 · Paper page
  22. Fitzpatrick, 2012, Case-control study of blink rate in Parkinson's disease under different conditions, J. Neurol., 259, 739, 10.1007/s00415-011-6261-0 · DOI
  23. Gallup, 1968, Mirror-image stimulation, Psychol. Bull., 70, 782, 10.1037/h0026777 · DOI · Paper page
  24. González-Martínez, 2013, Effect of age and severity of cognitive dysfunction on two simple tasks in pet dogs, Vet. J., 198, 176, 10.1016/j.tvjl.2013.07.004 · DOI
  25. Górecki, 1992, Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters, Hum. Mol. Genet., 1, 505, 10.1093/hmg/1.7.505 · DOI · Paper page
  26. Goyenvalle, 2015, Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers, Nat. Med., 21, 270, 10.1038/nm.3765 · DOI · Paper page
  27. Hendriksen, 2008, Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder, J. Child Neurol., 23, 477, 10.1177/0883073807309775 · DOI · Paper page
  28. Hildyard, 2018, Determination of qPCR reference genes suitable for normalizing gene expression in a canine model of Duchenne muscular dystrophy, J. Neuromuscul. Dis., 5, 177, 10.3233/JND-170267 · DOI
  29. Hildyard, 2019, Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy, PLoS ONE, 14, e0211384, 10.1371/journal.pone.0211384 · DOI
  30. Hildyard, 2020, Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo, Wellcome Open Res., 5, 76, 10.12688/wellcomeopenres.15762.1 · DOI
  31. Hildyard, 2020, Multiplex in situ hybridization within a single transcript: RNAscope reveals dystrophin mRNA dynamics, PLoS ONE, 15, e0239467, 10.1371/journal.pone.0239467 · DOI
  32. Hornby, 2021, Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy, Neuromuscul. Disord., 31, 736, 10.1016/j.nmd.2021.05.010 · DOI
  33. Hughes, 1994, Evidence for executive dysfunction in autism, Neuropsychologia, 32, 477, 10.1016/0028-3932(94)90092-2 · DOI · Paper page
  34. Klymiuk, 2013, Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle, Hum. Mol. Genet., 22, 4368, 10.1093/hmg/ddt287 · DOI · Paper page
  35. Knuesel, 1999, Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur. J. Neurosci., 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
  36. Kodippili, 2018, Dual AAV gene therapy for duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the Canine model, Hum. Gene. Ther., 29, 299, 10.1089/hum.2017.095 · DOI · Paper page
  37. Koenig, 1989, The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am. J. Hum. Genet., 45, 498
  38. Konrad, 2003, Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder, Brain Res. Cogn. Brain Res., 16, 425, 10.1016/S0926-6410(03)00057-0 · DOI
  39. Kornegay, 2017, The golden retriever model of Duchenne muscular dystrophy, Skelet. Muscle, 7, 9, 10.1186/s13395-017-0124-z · DOI · Paper page
  40. Landry, 2021, An examination of perseverative errors and cognitive flexibility in autism, PLoS ONE, 16, e0223160, 10.1371/journal.pone.0223160 · DOI
  41. Larcher, 2014, Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy, PLoS ONE, 9, e110371, 10.1371/journal.pone.0110371 · DOI · Paper page
  42. Lawrence, 1991, The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys, Life Sci., 49, PL229, 10.1016/0024-3205(91)90299-Q · DOI
  43. Lazarowski, 2014, Acquisition of a visual discrimination and reversal learning task by Labrador retrievers, Anim. Cogn., 17, 787, 10.1007/s10071-013-0712-1 · DOI
  44. Lederfein, 1992, A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues, Proc. Natl. Acad. Sci. USA, 89, 5346, 10.1073/pnas.89.12.5346 · DOI · Paper page
  45. Lidov, 1990, Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons, Nature, 348, 725, 10.1038/348725a0 · DOI · Paper page
  46. Lidov, 1995, Dp140 - a Novel 140-Kda Cns Transcript from the Dystrophin Locus, Hum. Mol. Genet., 4, 329, 10.1093/hmg/4.3.329 · DOI · Paper page
  47. Luria, 1969, Handbook of Clinical Neurology.
  48. Mah, 2014, A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy, Neuromuscul. Disord., 24, 482, 10.1016/j.nmd.2014.03.008 · DOI · Paper page
  49. Mavridis, 1991, Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease, Neuroscience, 41, 507, 10.1016/0306-4522(91)90345-O · DOI · Paper page
  50. McGreevy, 2015, Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy, Dis. Model. Mech., 8, 195, 10.1242/dmm.018424 · DOI · Paper page
  51. Milner, 1964, The Frontal Granular Cortex and Behaviour.
  52. Miranda, 2011, Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71, Neurobiol. Dis., 43, 134, 10.1016/j.nbd.2011.02.017 · DOI
  53. Muntoni, 1991, Passive avoidance behaviour deficit in the mdx mouse, Neuromuscul. Disord., 1, 121, 10.1016/0960-8966(91)90059-2 · DOI · Paper page
  54. Muntoni, 1993, Muscular weakness in the mdx mouse, J. Neurol. Sci., 120, 71, 10.1016/0022-510X(93)90027-V · DOI
  55. Naidoo, 2020, Dystrophin Dp71 and the neuropathophysiology of Duchenne muscular dystrophy, Mol. Neurobiol., 57, 1748, 10.1007/s12035-019-01845-w · DOI
  56. Nicholson, 1993, Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis, J. Med. Genet., 30, 745, 10.1136/jmg.30.9.745 · DOI
  57. Noer, 2015, Context matters: multiple novelty tests reveal different aspects of shyness-boldness in farmed american mink (Neovison vison), PLoS ONE, 10, e0130474, 10.1371/journal.pone.0130474 · DOI
  58. Nudel, 1989, Duchenne muscular dystrophy gene product is not identical in muscle and brain, Nature, 337, 76, 10.1038/337076a0 · DOI · Paper page
  59. Packer, 2018, Cognitive dysfunction in naturally occurring canine idiopathic epilepsy, PLoS ONE, 13, e0192182, 10.1371/journal.pone.0192182 · DOI
  60. Packer, 2018, Negative effects of epilsepsy and antiepileptic drugs on the trainability of dogs with naturally occurring idiopathic epilepsy, Appl. Anim. Behav. Sci., 200, 106, 10.1016/j.applanim.2017.11.008 · DOI
  61. Pane, 2013, Duchenne muscular dystrophy and epilepsy, Neuromuscul. Disord., 23, 313, 10.1016/j.nmd.2013.01.011 · DOI · Paper page
  62. Protopopova, 2014, Association between increased behavioral persistence and stereotypy in the pet dog, Behav. Processes, 106, 77, 10.1016/j.beproc.2014.04.009 · DOI
  63. Rall, 2012, Survival in Duchenne muscular dystrophy, 31, 117
  64. Remmelink, 2016, Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin, Genes Brain Behav., 15, 558, 10.1111/gbb.12301 · DOI · Paper page
  65. Sanchez, 2018, Clinical and genetic characterisation of dystrophin-deficient muscular dystrophy in a family of Miniature Poodle dogs, PLoS ONE, 13, e0193372, 10.1371/journal.pone.0193372 · DOI
  66. Sarig, 1999, Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development, Hum. Mol. Genet., 8, 1, 10.1093/hmg/8.1.1 · DOI
  67. Schütt, 2016, Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer's disease: a translational study of neuropathological and inflammatory markers, J. Alzheimers Dis., 52, 433, 10.3233/JAD-151085 · DOI · Paper page
  68. Sekiguchi, 2009, A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice, Brain, 132, 124, 10.1093/brain/awn253 · DOI · Paper page
  69. Sharp, 1992, An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy, Genomics, 13, 115, 10.1016/0888-7543(92)90210-J · DOI · Paper page
  70. Siwak, 2001, Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the beagle dog, Learn. Mem., 8, 317, 10.1101/lm.41701 · DOI
  71. Song, 2019, Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models, Nat. Med., 25, 1505, 10.1038/s41591-019-0594-0 · DOI · Paper page
  72. Supek, 2020, To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases, Trends Genet., 37, 657, 10.1016/j.tig.2020.11.002 · DOI · Paper page
  73. Sussman, 2002, Duchenne muscular dystrophy, J. Am. Acad. Orthop. Surg., 10, 138, 10.5435/00124635-200203000-00009 · DOI
  74. Sweeney, 2000, The dystrophin-associated glycoprotein complex: what parts can you do without?, Proc. Natl. Acad. Sci. USA, 97, 13464, 10.1073/pnas.011510597 · DOI
  75. Tadayoni, 2012, Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene, Mol. Neurobiol., 45, 43, 10.1007/s12035-011-8218-9 · DOI
  76. Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS ONE, 5, e8803, 10.1371/journal.pone.0008803 · DOI · Paper page
  77. Tennyson, 1995, The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced, Nat. Genet., 9, 184, 10.1038/ng0295-184 · DOI · Paper page
  78. Vaillend, 2017, Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice, Hum. Mol. Genet., 26, 1041, 10.1093/hmg/ddx013 · DOI · Paper page
  79. Vaillend, 2010, Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse, Mol. Ther., 18, 1683, 10.1038/mt.2010.134 · DOI · Paper page
  80. Waite, 2012, The dystrophin-glycoprotein complex in brain development and disease, Trends Neurosci., 35, 487, 10.1016/j.tins.2012.04.004 · DOI · Paper page
  81. Walhovd, 2001, Two- and three-stimuli auditory oddball ERP tasks and neuropsychological measures in aging, Neuroreport, 12, 3149, 10.1097/00001756-200110080-00033 · doi:10.1097/00001756-200110080-00033
  82. Walmsley, 2010, A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping, PLoS ONE, 5, e8647, 10.1371/journal.pone.0008647 · DOI
  83. Wang, 2012, Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies, Mol. Ther., 20, 1501, 10.1038/mt.2012.111 · DOI · Paper page

Cited by

Metadata

Authors
Crawford, A. H., Hildyard, J. C. W., Rushing, S. A. M., Wells, D. J., Diez-Leon, M., & Piercy, R. J.
Affiliations
  • Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services, Royal Veterinary College, London NW1 0TU, UK
  • Department of Comparative Biomedical Sciences, Royal Veterinary College, London NW1 0TU, UK
  • Pathobiology and Population Sciences, Royal Veterinary College, London AL9 7TA, UK
Venue
Disease Models & Mechanisms
Published
2022-03-01
Volume
15
Issue
3
ISSN
  • 1754-8403
  • 1754-8411
Cited by
17
References
6
Language
en
Funders
  • Wellcome Trust (101550/Z/13/Z)
  • Academy of Medical Sciences
  • Medical Research Council
  • British Heart Foundation
  • Versus Arthritis
  • Diabetes UK
  • British Thoracic Society
  • Association of Physicians of Great Britain and Ireland (SGL020\1081)
  • Royal Veterinary College (1185 1718)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.